Investigating the influence of ubiquinone blood level on the abilities of children with specific learning disorder
Open Access
- 27 November 2018
- journal article
- research article
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 54 (1) , 1-5
Abstract
Ubiquinone has antioxidant properties and has been linked to cognitive performance in some neuropsychiatric disorders. Its role in specific learning disorder manifestations has not been previously investigated. Therefore, the aim of this study was to measure the blood levels of ubiquinone in a group of children with specific learning disorder in comparison to typically developing children and to investigate the correlation between ubiquinone levels in children with specific learning disorder and some of their intellectual capabilities, reading, spelling and writing performance. The study included 71 native Arabic speaking children: 31 in the specific learning disorder group and 40 in the typically developing (TD) group. The abilities of the children with specific learning disorder were evaluated by the Stanford-Binet Intelligence Scale-4th edition, the Dyslexia Assessment Test, and the Illinois Test of Psycholinguistic Abilities. The level of ubiquinone was measured in both groups by ELISA. Correlation between some aptitudes of children with specific learning disorder and the ubiquinone level was performed. The blood levels of ubiquinone in the children with specific learning disorder group were less than those in the TD group. Correlation analysis revealed a significant positive correlation between ubiquinone and the scores of backward digit span abilities. Ubiquinone has a role in the auditory working memory performance of children with specific learning disorder (with impairment in reading). The decreased levels of ubiquinone in this sample of children with specific learning disorder could have participated in the pathogenesis of this disorder.Keywords
This publication has 18 references indexed in Scilit:
- Co-Activation-Based Parcellation of the Lateral Prefrontal Cortex Delineates the Inferior Frontal Junction AreaCerebral Cortex, 2015
- The Effect of Creatine and Coenzyme Q10 Combination Therapy on Mild Cognitive Impairment in Parkinson's DiseaseEuropean Neurology, 2015
- Functional neuroanatomical evidence for the double-deficit hypothesis of developmental dyslexiaNeuropsychologia, 2014
- Coenzyme Q10 treatment ameliorates cognitive deficits by modulating mitochondrial functions in surgically induced menopauseNeurochemistry International, 2014
- Age, dyslexia subtype and comorbidity modulate rapid auditory processing in developmental dyslexiaFrontiers in Human Neuroscience, 2014
- Chronic treatment with coenzyme Q10 reverses restraint stress-induced anhedonia and enhances brain mitochondrial respiratory chain and creatine kinase activities in ratsBehavioural Pharmacology, 2013
- Coenzyme Q10 Restores Amyloid Beta-Inhibited Proliferation of Neural Stem Cells by Activating the PI3K PathwayStem Cells and Development, 2013
- Reading Abilities: Importance of Visual-Spatial AttentionCurrent Biology, 2012
- A tractography study in dyslexia: neuroanatomic correlates of orthographic, phonological and speech processingBrain, 2012
- Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stressEpilepsy & Behavior, 2011